Moderna Stock Pops Despite Growing Losses On Massive Sales …

Feb 25, 2021 · Losses widened, but sales skyrocketed over 2019 numbers. Moderna stock has a bullish Relative Strength Rating of 97 out of a best-possible 99, according to IBD Digital. This …

CouponFollow Extension

$13
OFF

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024 · Cambridge, Mass.-based Moderna (MRNA) had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier …

morningstar.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

Jan 14, 2025 · Moderna reduced its previously announced sales guidance for 2025 by $1 billion. It now forecasts total revenues in the range of $1.5 to $2.5 billion, mainly from product sales of …

yahoo.com

$300
OFF

Moderna Shares Slide After Sales Guidance Slashed - Financial Times

2 weeks from now

Jan 13, 2025 · Big Tech lines up over $300bn in AI spending for 2025; ... Moderna shares slide after sales guidance slashed on facebook ... Moderna stock fell as low as $31.94, more than …

ft.com

$1
OFF

Moderna Surprises The Street By Predicting A Bigger-Than …

2 weeks from now

Jan 13, 2025 · Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. Analysts expect, on average, $2.92 billion …

usnews.com

91%
OFF

Moderna Posts Quarterly Sales Beat, Smaller Loss Than Expected

2 weeks from now

May 2, 2024 · Sales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ …

yahoo.com

$17
OFF

Analysts Tell Moderna Investors To Hold After 2024’s Steep Drop

2 weeks from now

Dec 17, 2024 · Moderna was the most shorted healthcare stock of the month on the S&P 500 in November, the report found. As 2024 comes to a close, Moderna has a market cap of $17 …

biospace.com

$400
OFF

Moderna Stock Plunges After Vaccine Sales Struggle - The Wall …

2 weeks from now

Jan 13, 2025 · The biotechnology company’s stock price, which once topped $400 when sales of its Covid-19 vaccine were booming in 2021, fell to $33.80 in recent trading. It is the worst …

wsj.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

Jan 14, 2025 · The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced an expanded cost-cutting initiative. Moderna Stock …

zacks.com

17%
OFF

Moderna Stock Crashes 17% After Covid Vaccine Maker Slashes …

2 weeks from now

Jan 13, 2025 · NOW PLAYING How To Sell Stocks: When To Cut Losses. The company now projects $3 billion to $3.1 billion in sales of its two products, below its previous call for $3 billion …

investors.com

21%
OFF

Moderna’s Stock Slides 21% After Company Lowers Full-year Sales ...

2 weeks from now

Aug 1, 2024 · Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue …

marketwatch.com

55%
OFF

Moderna Snaps Six Days Of Losses, Trades In Green - Seeking Alpha

2 weeks from now

Oct 25, 2024 · Moderna (NASDAQ:MRNA) shares traded in the green on Friday, snapping six consecutive days of losses.The stock closed up 0.55% at $53.09. MRNA stock fell about 31% …

seekingalpha.com

20%
OFF

Moderna: The Good News Isn't Enough - Seeking Alpha

2 weeks from now

5 days ago · In the roughly month-and-a-half since, Moderna dropped over 20%, only to be hit by a huge run of multiple news events, rallying back all the way to the current ~$43, roughly 5% …

seekingalpha.com

FAQs about Moderna Stock Pops Despite Growing Losses On Massive Sales … Coupon?

Why did Moderna stock fall 21%?

Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. It was the stock’s biggest-ever one-day decline and has erased all of its gains for the year to date. Already a subscriber? ...

Why did Moderna shares drop 22 per cent on Monday?

Moderna shares dropped as much as 22 per cent on Monday after the US biotech group’s sales forecasts disappointed investors. The Boston-based company projected sales this year of $1.5bn-$2.5bn, down from a previous forecast of $2.5bn-$3.5bn and lower than some analyst estimates for $2.4bn-$2.9bn. ...

Why did Moderna stock crash?

Moderna (MRNA) stock crashed Monday after the Covid vaccine maker slashed its outlook for 2024 and 2025 sales and announced an expanded cost-cutting initiative. The company now projects $3 billion to $3.1 billion in sales of its two products, below its previous call for $3 billion to $3.5 billion. ...

Is Moderna a good stock to buy?

Photo: joel saget/Agence France-Presse/Getty Images Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. ...

Why did Moderna's stock tumble 21% Thursday?

Moderna’s stock was slammed early Thursday after it cut its sales guidance. Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. ...

Why did Moderna share price plunge 2025?

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to be sluggish. ...